{
  "ConceptSets": [
    {
      "id": 3,
      "name": "Rivastigmine users",
      "expression": {
        "items": [
          {
            "concept": {
              "CONCEPT_CLASS_ID": "ATC 5th",
              "CONCEPT_CODE": "N06DA03",
              "CONCEPT_ID": 21604796,
              "CONCEPT_NAME": "rivastigmine; oral, transdermal",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "C",
              "STANDARD_CONCEPT_CAPTION": "Classification",
              "VOCABULARY_ID": "ATC"
            },
            "includeDescendants": true
          }
        ]
      }
    }
  ],
  "PrimaryCriteria": {
    "CriteriaList": [
      {
        "DrugExposure": {
          "CodesetId": 3
        }
      }
    ],
    "ObservationWindow": {
      "PriorDays": 0,
      "PostDays": 0
    },
    "PrimaryCriteriaLimit": {
      "Type": "First"
    }
  },
  "QualifiedLimit": {
    "Type": "First"
  },
  "ExpressionLimit": {
    "Type": "First"
  },
  "InclusionRules": [],
  "CensoringCriteria": [],
  "CollapseSettings": {
    "CollapseType": "ERA",
    "EraPad": 0
  },
  "CensorWindow": {},
  "cdmVersionRange": ">=5.0.0"
}